HK1130054A1 - Novel, acyclic substituted furopyrimidine derivatives and use thereof - Google Patents

Novel, acyclic substituted furopyrimidine derivatives and use thereof

Info

Publication number
HK1130054A1
HK1130054A1 HK09108053.8A HK09108053A HK1130054A1 HK 1130054 A1 HK1130054 A1 HK 1130054A1 HK 09108053 A HK09108053 A HK 09108053A HK 1130054 A1 HK1130054 A1 HK 1130054A1
Authority
HK
Hong Kong
Prior art keywords
novel
acyclic substituted
furopyrimidine derivatives
substituted furopyrimidine
derivatives
Prior art date
Application number
HK09108053.8A
Other languages
English (en)
Inventor
Thomas Lampe
Eva-Maria Becker
Raimund Kast
Hartmut Beck
Mario Jeske
Joachim Schuhmacher
Friederike Stoll
Martina Klein
Metin Akbaba
Andreas Knorr
Johannes-Peter Stasch
Lars Baerfacker
Alexander Hillisch
Gunter Karig
Mark Meininghaus
Karl-Heinz Schlemmer
Rudolf Schohe-Loop
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HK1130054A1 publication Critical patent/HK1130054A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK09108053.8A 2005-12-21 2009-09-03 Novel, acyclic substituted furopyrimidine derivatives and use thereof HK1130054A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061170A DE102005061170A1 (de) 2005-12-21 2005-12-21 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
PCT/EP2006/011826 WO2007079862A1 (de) 2005-12-21 2006-12-08 Neue, acyclisch substituierte furopyrimidin-derivate und ihre verwendung zur behandlung von kardiovaskulären erkrankungen

Publications (1)

Publication Number Publication Date
HK1130054A1 true HK1130054A1 (en) 2009-12-18

Family

ID=37876878

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108053.8A HK1130054A1 (en) 2005-12-21 2009-09-03 Novel, acyclic substituted furopyrimidine derivatives and use thereof

Country Status (32)

Country Link
US (1) US8183246B2 (es)
EP (1) EP1966217B1 (es)
JP (1) JP5254032B2 (es)
KR (1) KR101429777B1 (es)
CN (1) CN101384603B (es)
AR (1) AR058108A1 (es)
AU (1) AU2006334856B2 (es)
BR (1) BRPI0620317A2 (es)
CA (1) CA2633701C (es)
CR (1) CR10092A (es)
DE (1) DE102005061170A1 (es)
DK (1) DK1966217T3 (es)
DO (1) DOP2006000280A (es)
EC (1) ECSP088569A (es)
ES (1) ES2418855T3 (es)
GT (1) GT200800117A (es)
HK (1) HK1130054A1 (es)
IL (1) IL192062A0 (es)
MA (1) MA30039B1 (es)
NO (1) NO20082986L (es)
NZ (1) NZ569214A (es)
PE (1) PE20071168A1 (es)
PL (1) PL1966217T3 (es)
PT (1) PT1966217E (es)
RU (1) RU2454419C2 (es)
SV (1) SV2009002953A (es)
TN (1) TNSN08279A1 (es)
TW (1) TWI405764B (es)
UA (1) UA94080C2 (es)
UY (1) UY30046A1 (es)
WO (1) WO2007079862A1 (es)
ZA (1) ZA200805385B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007019691A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007051762A1 (de) * 2007-10-30 2009-05-07 Bayer Healthcare Ag Substituierte Pyrrolotriazine und ihre Verwendung
DE102007054786A1 (de) * 2007-11-16 2009-05-20 Bayer Healthcare Ag Trisubstituierte Furopyrimidine und ihre Verwendung
EP2848621A4 (en) 2012-05-10 2016-06-01 Takeda Pharmaceutical AROMATIC CYCLIC COMPOUND
WO2013168760A1 (ja) 2012-05-10 2013-11-14 武田薬品工業株式会社 芳香環化合物
US11434247B1 (en) 2017-11-27 2022-09-06 Dart Neuroscience Llc Substituted furanopyrimidine compounds as PDE1 inhibitors
JP2022533570A (ja) 2019-05-13 2022-07-25 リレー セラピューティクス， インコーポレイテッド Ｆｇｆｒ阻害剤およびそれらの使用
KR102094337B1 (ko) 2019-10-01 2020-03-27 안문호 금속이물질 제거장치

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577420A (en) * 1968-01-05 1971-05-04 Pfizer Certain 4-aminofuro(2,3-d)pyrimidines
WO2000005234A1 (fr) 1998-07-22 2000-02-03 Suntory Limited INHIBITEURS DE NF-λB CONTENANT DES DERIVES D'INDANE EN TANT QU'INGREDIENT ACTIF
WO2000075145A1 (en) 1999-06-03 2000-12-14 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CN1212861C (zh) 1999-09-17 2005-08-03 第一三得利制药株式会社 以NF－κB抑制剂为有效成分的心肌炎、扩张型心肌病和心衰的预防或治疗药
ES2259707T3 (es) 2001-05-14 2006-10-16 Novartis Ag Oxazolo y furopirimidinas y su uso en medicamentos contra tumores.
DE10141212A1 (de) * 2001-08-22 2003-03-06 Bayer Ag Neue 4-Aminofuropyrimidine und ihre Verwendung
JP2005508904A (ja) 2001-09-11 2005-04-07 スミスクライン ビーチャム コーポレーション 血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
US20030225098A1 (en) 2002-03-21 2003-12-04 Hirst Gavin C. Kinase inhibitors
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
CA2568304A1 (en) 2004-06-10 2005-12-22 Xention Discovery Limited Furanopyrimidine compounds effective as potassium channel inhibitors
WO2006004658A2 (en) 2004-06-29 2006-01-12 Amgen Inc. Furanopyrimidines

Also Published As

Publication number Publication date
DOP2006000280A (es) 2007-07-31
PL1966217T3 (pl) 2013-09-30
AU2006334856A1 (en) 2007-07-19
TWI405764B (zh) 2013-08-21
US8183246B2 (en) 2012-05-22
CN101384603B (zh) 2012-08-01
PE20071168A1 (es) 2008-02-07
NZ569214A (en) 2011-07-29
DK1966217T3 (da) 2013-08-05
CA2633701C (en) 2014-05-27
BRPI0620317A2 (pt) 2011-11-08
KR20080081323A (ko) 2008-09-09
UY30046A1 (es) 2007-07-31
AR058108A1 (es) 2008-01-23
CA2633701A1 (en) 2007-07-19
WO2007079862A1 (de) 2007-07-19
TNSN08279A1 (en) 2009-10-30
ES2418855T3 (es) 2013-08-16
RU2008129363A (ru) 2010-01-27
NO20082986L (no) 2008-07-02
US20090318475A1 (en) 2009-12-24
PT1966217E (pt) 2013-07-12
GT200800117A (es) 2009-12-16
TW200745132A (en) 2007-12-16
UA94080C2 (ru) 2011-04-11
CR10092A (es) 2008-10-08
DE102005061170A1 (de) 2007-07-05
EP1966217B1 (de) 2013-05-08
KR101429777B1 (ko) 2014-08-19
AU2006334856B2 (en) 2013-04-04
ZA200805385B (en) 2009-10-28
JP2009520713A (ja) 2009-05-28
ECSP088569A (es) 2008-08-29
RU2454419C2 (ru) 2012-06-27
CN101384603A (zh) 2009-03-11
SV2009002953A (es) 2009-04-28
IL192062A0 (en) 2008-12-29
EP1966217A1 (de) 2008-09-10
JP5254032B2 (ja) 2013-08-07
MA30039B1 (fr) 2008-12-01

Similar Documents

Publication Publication Date Title
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
ZA200709043B (en) Benzodioxane and benzodioxalane derivatives and uses thereof
IL191655A0 (en) Novel compounds, their preparation and use
IL187163A0 (en) Novel fluorene derivatives, composition containing said derivatives and the use thereof
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
IL180481A0 (en) Aryl-pyridine derivatives
HK1130054A1 (en) Novel, acyclic substituted furopyrimidine derivatives and use thereof
IL179736A0 (en) Pyrrazolo-pyrimidine derivatives
IL177968A0 (en) Tetrahydropyridoindole derivatives
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
IL183140A0 (en) Substituted benzoquinolizine derivatives
EP1951682A4 (en) NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
IL177204A0 (en) Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
IL182585A0 (en) Imidazo-benzodiazepine derivatives
EP1737458A4 (en) R (-) - 11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
IL179068A0 (en) Substituted enaminones, their derivatives and uses thereof
HK1100002A1 (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
HK1100775A1 (en) 4-Amino-5-cyanopyrimidine derivatives
GB0414272D0 (en) OsK1 derivatives
TWI367222B (en) Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
IL177759A0 (en) Cospeptin, cosmedin and their uses
IL182001A0 (en) 2-acylaminothiazole derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161208